Double-seropositive myasthenia gravis

Muscle and Nerve

Volumn 47, Issue 3, 2013, Pages 465-466

  Zouvelou, Vasiliki ^a   Kyriazi, Stavroula ^b   Rentzos, Michael ^a   Belimezi, Maria ^c   Micheli, Maria Angeliki ^a   Tzartos, Socrates J ^c   Stamboulis, Eleftherios ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; MUSCLE SPECIFIC TYROSINE KINASE; PREDNISOLONE; PROTEIN TYROSINE KINASE; PYRIDOSTIGMINE; UNCLASSIFIED DRUG;

ADULT; BICEPS BRACHII MUSCLE; BLURRED VISION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSARTHRIA; DYSPHAGIA; ELECTROMYOGRAPHY; FEMALE; HUMAN; LETTER; MYASTHENIA GRAVIS; NERVE CONDUCTION; NERVE STIMULATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBICULARIS OCULI MUSCLE; PRIORITY JOURNAL; PTOSIS; SPEECH DISORDER; TREATMENT RESPONSE;

ADULT; ELECTROMYOGRAPHY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MYASTHENIA GRAVIS; NEUROLOGIC EXAMINATION; PROGNOSIS; SPEECH DISORDERS;

EID: 84874231851     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23645     Document Type: Letter

References (9)

1. Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R, et al. MRI and clinical studies of facial and bulbar muscle involvement in MuSK-antibody-associated myasthenia gravis. Brain 2006;129:1481-1492.
2. Oh SJ, Hatanaka Y, Hemmi S, Young AM, Scheufele ML, Nations SP, et al. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis. Muscle Nerve 2006;33:500-504.
3. Hatanaka Y, Hemmi S, Morgan MB, Scheufele ML, Claussen GC, Wolfe GI. Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG. Neurology 2005;65:1508-1509.
4. Punga AR, Flink R, Askmark H, Stalberg EV. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody. Muscle Nerve 2006;34:111-115.
5. McConville J, Farrugia ME, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J, et al. Detection and characterization of MuSK Abs in seronegative myasthenia gravis. Ann Neurol 2004;55:580-584.
6. Punga RA, Ahlqvist K, Bartoccioni E, Scuderi F, Marino M, Suomalainen A, et al. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes. Clin Neurophysiol 2006;117:1434-1443.
7. Sanders DB, Juel VC. MuSK-antibody positive myasthenia gravis. Questions from the clinic. J Neuroimmunol 2008;201-202:85-89.
8. Poulas K, Koutsouraki E, Kordas G, Kokla A, Tzartos SJ. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by D-penicillamine. J Neuroimmunol 2012;250:94-98.
9. Suhail H, Vivekanandhan S, Singh S, Behari M. Coexistent of muscle specific tyrosine kinase and acetylcholine receptor antibodies in a myasthenia gravis patient. Neurol India 2010;58:668-669.